Neoadjuvant trastuzumab emtansine and pertuzumab in human epidermal growth factor receptor 2–positive breast cancer: Three-year outcomes from the phase III KristinE study
- Sara A. Hurvitz
- , Miguel Martin
- , Kyung Hae Jung
- , Chiun Sheng Huang
- , Nadia Harbeck
- , Vicente Valero
- , Daniil Stroyakovskiy
- , Hans Wildiers
- , Mario Campone
- , Jean François Boileau
- , Peter A. Fasching
- , Karen Afenjar
- , Gonzalo Spera
- , Vanesa Lopez-Valverde
- , Chunyan Song
- , Peter Trask
- , Thomas Boulet
- , Joseph A. Sparano
- , W. Fraser Symmans
- , Alastair M. Thompson
Research output: Contribution to journal › Article › peer-review
249
Scopus
citations